FibroBiologics, Inc.
News
(2)April 2026
FBLG Proxy Statement outlines director elections and key corporate approvals
# 📜 What This Document Is 📰 This document is a Preliminary Proxy Statement (PRE 14A), which is a critical filing that tells stockholders what they will be asked to vote on at the upcoming Annual Meeting of Stockholders. Simply put, it is a "how-to guide" and a "here's what we want you to approve"
FBLG achieves Nasdaq listing compliance, stabilizing its market presence
# 📰 What This Document Is 📄 This document is a filing called an 8-K, which is a critical regulatory notice to the market. It means that FibroBiologics, Inc. is announcing a major, material event that happened *after* the company's regular financial reporting. Instead of a detailed quarterly repor
Peers in Biotechnology
Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.